The Enforcement Directorate (ED) launched a search operation at seven locations in Chennai connected to the ongoing investigation of Coldrif cough syrup after the deaths of many children. The searches were carried out at locations related to...
The Association of Indian Medical Device Industry (AiMeD) has indeed welcomed the initiative taken by the Indian Government to speed up GST refunds for exporters and manufacturers
Jubilant Pharmova declared that its wholly owned subsidiary, Jubilant HollisterStier LLC (JHS), a major contract manufacturer specializing in sterile injectables in the North American pharmaceutical industry
Integris Medtech is the second-biggest medical technology platform in India that is diversified. It has submitted the Draft Red Herring Prospectus (DRHP) to the Securities and Exchange Board of India
Nanomi B.V. (Nanomi) announced that a pharmaceutical company of global repute Lupin Limited (Lupin) has established a new strategic alliance programme which would make the long-acting injectable (LAI) platform PrecisionSphere more accessible.
Lonza, a global leader in contract development and manufacturing (CDMO), has declared that the operational readiness of its new aseptic drug product filling line at its Stein, Switzerland site is in place.
India's pharmaceutical industry, which is frequently hailed as the "pharmacy of the world," serves as a vital contributor in the delivery of reasonably priced medicines across more than 200 nations. Recent occurrences concerning defective cough syrup
The National Accreditation Board for Testing and Calibration Laboratories (NABL) has initiated the Medical Entry Level Testing (MELT) Labs Programme to propagate quality practices in medical testing laboratories throughout India.
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has given its green light to Zydus Healthcare Limited for the production and sale of Sodium Chloride Nebuliser Solution BP 3% w/v.
Viren Shetty, Executive Vice Chairman of Narayana Health, emphasized that drugs alone cannot transform outcomes—India needs integration between hospitals, insurers, and pharma to ensure innovation reaches patients at scale.
.jpg)
, CDSCO.jpg)